Copyright
©The Author(s) 2015.
World J Clin Oncol. Oct 10, 2015; 6(5): 156-165
Published online Oct 10, 2015. doi: 10.5306/wjco.v6.i5.156
Published online Oct 10, 2015. doi: 10.5306/wjco.v6.i5.156
Table 1 Patient characteristics (n = 16)
| Characteristic | n (%) | Characteristic | n (%) |
| Sex | Performance status | ||
| Male | 5 (31) | 0 | 7 (44) |
| Female | 11 (69) | 1 | 9 (57) |
| Age | Stage | ||
| Mean | 63.25 | IIIA | 7 (44) |
| Median | 61 | IIIB | 7 (44) |
| Range | 49-78 | III NOS | 2 (13) |
| Race | Smoking status | ||
| White | 11 (69) | Current | 3 (19) |
| Black | 2 (13) | Former | 13 (81) |
| Other | 3 (19) | ||
| Histology | |||
| Adenocarcinoma | 8 | ||
| Squamous Cell | 6 | ||
| NSCLC-NOS | 2 | ||
- Citation: Mix M, Ramnath N, Gomez J, Groot C, Rajan S, Dibaj S, Tan W, Rustum Y, Jameson MB, Singh AK. Effects of selenomethionine on acute toxicities from concurrent chemoradiation for inoperable stage III non-small cell lung cancer. World J Clin Oncol 2015; 6(5): 156-165
- URL: https://www.wjgnet.com/2218-4333/full/v6/i5/156.htm
- DOI: https://dx.doi.org/10.5306/wjco.v6.i5.156